Astex and CRT progress new anticancer
This article was originally published in Scrip
Executive Summary
Astex Pharmaceuticals, with its collaborators Cancer Research UK and its commercial arm Cancer Research Technology, has begun clinical testing of the anticancer drug AT13148, which is being investigatedI in a range of cancer indications.